Investing is often filled with tough choices and opportunity costs. This game segment from The Motley Fool's Where The Money Is poses a hypothetical question:
Would you rather buy VIVUS (Nasdaq: VVUS) or buy Arena (NASDAQ: ARNA)?
Healthcare analysts David Williamson and Michael Douglass continue their game of "would you rather" by discussing two competing obesity drug makers struggling with lackluster sales. Watch and find out which stock David chooses and his arguments for it.
Will this stock be your next multi-bagger?
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.